Goldman Sachs
GS
$1094.44
-1.08%
Goldman Sachs Group Inc. is a leading global financial institution operating primarily in the capital markets, with core businesses spanning investment banking, global markets trading, asset and wealth management, and lending. The firm is a dominant market leader, particularly in high-margin advisory services where it has been the top global M&A advisor by revenue for two decades, and has strategically expanded into more stable, fee-based businesses to diversify its revenue streams. The current investor narrative is heavily focused on a potential revival in capital markets activity, driven by catalysts like the record-breaking SpaceX IPO, which promises to significantly boost investment banking fees, while the broader debate centers on the firm's ability to navigate a higher-for-longer interest rate environment that supports lending margins but pressures valuations.…
GS
Goldman Sachs
$1094.44
Related headlines
Investment Opinion: Should I buy GS Today?
Rating & Thesis: Goldman Sachs is a Hold. The core thesis is that while the stock offers compelling value and powerful cyclical catalysts, these are balanced by significant cash flow concerns and technical overextension after a massive rally, warranting a cautious stance pending clearer confirmation of a sustained earnings recovery.
Supporting Evidence: The primary valuation metric, a trailing P/E of 16.00x, represents a 27% discount to the sector, suggesting undervaluation. Revenue trends, while still negative YoY at -6.6%, showed sequential improvement from -9.4% in the prior quarter, hinting at a potential bottom. Profitability is recovering, with net income climbing from $3.72B to $4.62B over the last two quarters and gross margin expanding to 51.71%. However, the deeply negative free cash flow of -$47.22B severely undermines the quality of these earnings, a critical offsetting factor.
Risks & Conditions: The two biggest risks are the failure of investment banking activity to materially recover, invalidating the growth thesis, and a deterioration in the macro environment that pressures the stock's high beta of 1.29. This Hold rating would upgrade to a Buy if quarterly free cash flow turns sustainably positive or if the P/E discount widens further toward 20% below the sector average on a forward basis. It would downgrade to a Sell if revenue growth fails to turn positive in the next two quarters or if the stock breaks below key technical support around $900. Relative to its history and peers, the stock is fairly valued, balancing its discount with its cyclical risks.
Sign up to view all
GS 12-Month Price Forecast
Goldman Sachs presents a classic GARP (Growth at a Reasonable Price) dilemma with heightened cyclicality. The 27% sector discount on P/E is attractive, but it is rightly offset by the firm's reliance on volatile capital markets, evidenced by the revenue decline and negative cash flow. The technical picture shows immense momentum, but this also suggests the near-term recovery is largely priced in. The stance is neutral with medium confidence because the outcome is binary and data-dependent: strong confirmation of the banking recovery in the next two quarters would justify a bullish shift, while a miss would likely validate the bear case. The key monitorable is the conversion of earnings into cash; sustainable positive FCF would be the most convincing signal to upgrade the view.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Goldman Sachs's 12-month outlook, with a consensus price target around $1422.77 and implied upside of +30.0% versus the current price.
Average Target
$1422.77
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$876 - $1423
Analyst target range
Analyst coverage for Goldman Sachs appears limited in the provided dataset, with only 5 analysts cited for earnings estimates, and no explicit consensus price target, buy/hold/sell distribution, or target range is available in the data. The institutional ratings data shows recent actions from major firms, with a mix of 'Neutral' (JP Morgan), 'Market Perform' (KBW), 'Sector Perform' (RBC), 'Overweight' (Wells Fargo, Barclays), and 'Hold' (Freedom Broker), indicating a generally cautious to moderately bullish sentiment but lacking a strong, unified directional call. The absence of a clear consensus target price and the limited number of analysts cited suggests there may be insufficient standardized coverage data provided to calculate a precise upside/downside implication, which is unusual for a large-cap stock like Goldman Sachs and may point to a data gap in the inputs. A wide target range, if it existed, would signal high uncertainty around the stock's path, often tied to macroeconomic and capital markets volatility, while a tight range would indicate stronger conviction in the firm's strategic execution and earnings trajectory.
Bulls vs Bears: GS Investment Factors
The investment debate for Goldman Sachs centers on a powerful cyclical recovery thesis clashing with persistent structural risks. The bull case, currently supported by stronger evidence from technical momentum and a compelling valuation discount, hinges on a sustained revival in capital markets activity and stable interest rates. The bear case is anchored in the firm's high cyclicality, negative cash flow, and elevated leverage. The single most important tension is the timing and magnitude of the investment banking recovery. If catalysts like the SpaceX IPO successfully reignite a durable fee-generating cycle, the current P/E discount will close rapidly, driving significant upside. However, if the recovery proves fleeting or macro conditions tighten, the stock's high beta and cash flow issues could trigger a sharp re-rating towards its 52-week low.
Bullish
- Deep Discount to Sector Valuation: Goldman Sachs trades at a trailing P/E of 16.00x, a 27% discount to the implied industry average of 22x. This significant discount for a market leader suggests a potential value opportunity, especially if earnings recover as anticipated.
- Powerful Technical Uptrend and Momentum: The stock is up 72.62% over the past year and 34.79% over the past three months, significantly outperforming the SPY. Trading at 97.5% of its 52-week high ($1125), this momentum signals strong bullish conviction, likely fueled by catalysts like the SpaceX IPO.
- Improving Profitability and Margins: Q4 2025 net income rebounded to $4.62B from $3.72B in Q2 2025, and gross margin expanded to 51.71% from 46.17% in Q3. This sequential improvement in profitability and revenue quality indicates the cyclical downturn may be bottoming out.
- Catalyst from Capital Markets Revival: The record-breaking SpaceX IPO is a major catalyst for investment banking fees, signaling a potential reopening of the IPO market. As the top global M&A advisor, Goldman is uniquely positioned to capture a significant share of this revived activity.
Bearish
- Deeply Negative Free Cash Flow: Trailing-twelve-month free cash flow is -$47.22 billion, with Q4 2025 operating cash flow at -$16.28 billion. This indicates earnings are not converting to cash, raising concerns about capital allocation and financial flexibility despite reported profits.
- High Cyclical Volatility and Beta: The stock's beta of 1.29 indicates it is 29% more volatile than the market. This high sensitivity to interest rate and capital markets cycles makes the stock vulnerable to sharp pullbacks if the macro environment deteriorates or growth expectations falter.
- Revenue Decline and High Concentration: Q4 2025 revenue declined 6.6% year-over-year, and the Global Markets division ($20.63B) generates more than double the revenue of Investment Management. This reliance on volatile trading revenue exposes the firm to market downturns, despite diversification efforts.
- Elevated Leverage and High Debt: The debt-to-equity ratio of 4.88 is high, typical for a major bank but still a source of financial risk. In a rising rate or recessionary environment, this leverage could pressure net interest margins and amplify earnings volatility.
GS Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 72.62% gain over the past year. With a current price of $1096.56, it is trading at approximately 97.5% of its 52-week high of $1125, indicating it is near peak momentum levels, which suggests strong bullish sentiment but also raises concerns about potential overextension. The stock has significantly outperformed the broader market, with a relative strength of 47.63% over the past year, highlighting its leadership role in the financial sector's rally. Recent momentum remains exceptionally strong, with the stock up 18.07% over the past month and 34.79% over the past three months, far outpacing the SPY's gains of 0.74% and 15.14%, respectively, over the same periods. This acceleration in short-term gains, building on the longer-term uptrend, signals robust buying pressure, likely fueled by positive catalysts like the SpaceX IPO and supportive rate environment. Key technical support is anchored at the 52-week low of $630.01, while immediate resistance sits at the 52-week high of $1125; a decisive breakout above this level could signal a continuation of the bullish trend, while a failure could lead to consolidation. The stock's beta of 1.29 indicates it is approximately 29% more volatile than the SPY, which is material for risk management, especially given the stock's significant run-up and sensitivity to interest rate and capital markets cycles.
Beta
1.29
1.29x market volatility
Max Drawdown
-19.8%
Largest decline past year
52-Week Range
$653-$1125
Price range past year
Annual Return
+69.2%
Cumulative gain past year
| Period | GS Return | S&P 500 |
|---|---|---|
| 1m | +9.8% | -1.6% |
| 3m | +30.0% | +11.7% |
| 6m | +20.2% | +6.3% |
| 1y | +69.2% | +22.2% |
| ytd | +19.7% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GS Fundamental Analysis
Revenue growth has been volatile but showed a sequential improvement in the most recent quarter, with Q4 2025 revenue of $30.13 billion representing a -6.6% year-over-year decline, though this was an improvement from the -9.4% YoY decline in Q3 2025. The revenue segment data indicates the Global Markets division ($20.63B) is the primary revenue driver, more than double the size of the Investment Management segment ($9.22B), highlighting the firm's continued reliance on trading and market-making activities. The multi-quarter trend shows revenue stabilizing after a sharper decline earlier in 2025, suggesting the cyclical downturn in investment banking may be bottoming out, which is critical for the growth narrative. The company remains highly profitable, with Q4 2025 net income of $4.62 billion and a net margin of 15.33%. Gross margin for the quarter was 51.71%, showing an expansion from 46.17% in Q3 2025, indicating improved revenue quality or cost management. The trajectory over recent quarters shows net income rebounding from $3.72 billion in Q2 2025 to $4.62 billion in Q4 2025, signaling a recovery in profitability, which is a positive fundamental shift for the investment case. The balance sheet shows significant leverage typical for a major bank, with a debt-to-equity ratio of 4.88, but this is managed within a robust financial structure. A key concern is the trailing-twelve-month free cash flow of -$47.22 billion, which is deeply negative and reflects substantial investments and changes in working capital; however, quarterly cash flow statements show high volatility, with Q4 2025 operating cash flow at -$16.28 billion but Q3 2025 at a positive $2.68 billion. The Return on Equity (ROE) of 13.74% is solid for the financial sector, indicating efficient use of shareholder capital, but the negative free cash flow underscores that earnings are not yet fully converting to cash, a point for monitoring.
Quarterly Revenue
$30.1B
2025-12
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$-47.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GS Overvalued?
Given the company's substantial net income of $4.62 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.00x, while the forward PE is slightly higher at 16.71x; the minimal gap between trailing and forward multiples suggests the market is pricing in only modest near-term earnings growth expectations. Compared to the provided industry average PE of 22x (implied from the data stating a 59% premium would equate to a 35x PE), Goldman's trailing PE of 16.00x represents a significant 27% discount to the sector, which is notable for a market leader. This discount may reflect the market's perception of higher cyclical risk and volatility in Goldman's capital markets-centric model compared to more diversified financial peers, or it could indicate a value opportunity if the capital markets recovery accelerates. Historically, the stock's own PE ratio has fluctuated widely, from a low around 8.4x in early 2024 to a high near 22.7x in mid-2023. The current trailing PE of 16.00x sits roughly in the middle of this multi-year range, suggesting the stock is neither priced for extreme pessimism nor excessive optimism, but rather a balanced view of its earnings recovery potential and cyclical risks.
PE
16.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Goldman Sachs faces significant financial risks stemming from its highly leveraged balance sheet, with a debt-to-equity ratio of 4.88, which could amplify losses in a downturn. The deeply negative trailing free cash flow of -$47.22 billion is a major concern, indicating substantial capital is tied up in working capital or investments, limiting financial flexibility despite a solid 13.74% ROE. Furthermore, revenue remains concentrated in the volatile Global Markets division, which at $20.63B is more than double the size of the more stable Investment Management segment, creating earnings volatility as evidenced by the -6.6% YoY revenue decline in Q4 2025.
Market & Competitive Risks: The stock's primary market risk is valuation compression, as its current trailing P/E of 16.00x, while at a discount, could contract further if the anticipated capital markets revival stalls. With a beta of 1.29, the stock is highly sensitive to macroeconomic shifts, particularly changes in interest rate expectations which directly impact trading revenues and lending margins. Recent news highlights the risk of a 'higher-for-longer' rate environment pressuring stock valuations broadly, while competitive intensity for lucrative advisory mandates remains fierce, threatening Goldman's dominant but not unassailable market position.
Worst-Case Scenario: The most damaging scenario would involve a double-whammy of a stalled capital markets recovery coinciding with a sharp economic slowdown. This would trigger a collapse in trading and advisory fees, compress net interest margins, and potentially lead to credit losses. In this adverse environment, the stock could realistically re-test its 52-week low of $630.01, representing a downside of approximately -43% from the current price near $1096. Such a drawdown is plausible given the stock's historical volatility, a beta of 1.29, and the -19.84% max drawdown observed in the recent data period, which would be exacerbated by the negative cash flow constraining the firm's ability to support its share price.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Deeply negative free cash flow (-$47.22B TTM) and high leverage (D/E of 4.88) constrain financial flexibility. 2) Cyclical/Market Risk: Revenue is highly dependent on volatile capital markets activity (Global Markets is 2x larger than Investment Management), and the stock's beta of 1.29 makes it sensitive to macro shifts. 3) Execution Risk: The firm's ability to capture the promised investment banking revival is not guaranteed, and competition for mandates is intense. 4) Valuation Risk: After a 72.6% annual rally, the stock is trading near its 52-week high, leaving it vulnerable to profit-taking if growth catalysts disappoint.
The 12-month forecast for GS is a range of scenarios with a neutral base case. The bull case (30% probability) targets $1125-$1250, driven by a strong capital markets revival and multiple expansion. The base case (50% probability) targets $1000-$1125, assuming a modest recovery in banking fees and stable trading, with the P/E multiple holding around 16-18x. The bear case (20% probability) sees a retracement to $630-$850 if the recovery stalls and macro conditions worsen. The base case is most likely, predicated on the assumption that the recent sequential improvement in profitability continues but is hampered by ongoing cash flow volatility.
GS appears fairly valued relative to its own risk profile but undervalued compared to the broader sector. Its trailing P/E of 16.00x is a 27% discount to the implied industry average of 22x, suggesting undervaluation. However, this discount exists because the market prices in higher cyclical risk and cash flow concerns. Historically, its P/E has ranged from ~8.4x to ~22.7x, placing the current multiple in the middle, indicating a balanced view. The valuation implies the market expects a modest earnings recovery but remains skeptical of a return to peak profitability, making it fairly priced for the observable fundamentals.
GS is a conditional buy for investors with a specific risk profile. The stock offers a 27% P/E discount to its sector and powerful catalysts from a potential capital markets revival, like the SpaceX IPO. However, it carries substantial risks, including deeply negative free cash flow (-$47.22B TTM), high volatility (beta of 1.29), and reliance on cyclical revenues. It is a good buy for investors who are bullish on the near-term economic cycle and can tolerate the downside risk of a -43% drawdown to its 52-week low. A more conservative investor should wait for evidence of sustainable positive cash flow generation.
GS is more suitable for a medium-term, tactical investment horizon of 12-24 months rather than a long-term buy-and-hold or short-term trade. Its cyclical nature means performance is tightly linked to the capital markets cycle, which typically lasts a few years. The high beta of 1.29 and recent 18% one-month gain also indicate significant short-term volatility, making it risky for traders without a strong view on near-term catalysts. Given the current stage of potential recovery, a minimum holding period through at least the next two earnings cycles is advised to assess whether the growth thesis is playing out. It is not a core, set-and-forget long-term holding due to its inherent earnings volatility.